The Director of Public Health has approved the request to grant the authority to re-procure the Pharmacy Supervised Consumption service in accordance with CPR 7.1 (below £10k low value procurement) using a non-competitive process for a three year contract period commencing 1 July 2018 with the option to extend up to a further 3 years with an annual budget of £600k.
The pharmacy supervised consumption service is an integral part of treatment for opiate substance misuse. Existing contracts expire on 30 June 2018 and re-procurement of the service from 1 July 2018 is considered essential in maintaining safe and effective drug treatment for Leeds residents.
This is deemed to be a low value procurement in accordance with CPR 7.1 as each pharmacy is remunerated on a transactional basis for each supervised consumption intervention per client at a rate of £1.45 for methadone and £2.85 for buprenorphine. There is no guarantee that a pharmacy will receive any payment as each service user is free to select which pharmacy they use.
The total cost of provision that will be incurred across all pharmacy contracts is expected to be in the region of £600k p.a. which makes re-procurement of the service a key decision and subject to call-in.